Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06582628
Title Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC) (TEAM PC)
Acronym TEAM PC
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Fundacion Oncosur
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.